Privi Biotechnologies Private Limited

Privi Biotechnologies Private Limited - life sciences in Navi Mumbai, Maharashtra, India. FY 2026 financials & compliance.
CIN U74220MH1985PTC037534 Incorporated 20 September 1985 ROC Mumbai HQ Navi Mumbai, Maharashtra, India
Active Private Limited Company life sciences
Data last updated
Revenue · FY 2025
₹6.15 Cr
▼ 32% YoY
Net loss · FY 2025
₹7.6 Cr
Net margin -123.7%
EBITDA · FY 2025
-₹5.3 Cr
EBITDA margin -86.2%
Authorised capital
₹40 Cr
Registered with MCA
Paid-up capital
₹36.27 Cr
Issued & subscribed
Open charges
₹87.5 Lakh
Satisfied ₹22.2 Cr
Company age
41 yrs
Est. 1985
Employees · EPFO
38
Provident fund records

About Privi Biotechnologies Private Limited

Data last updated:

Privi Biotechnologies Private Limited is a private limited company based in Navi Mumbai, Maharashtra, India, a subsidiary of Privi Speciality Chemicals Limited. It operates in the biotechnology segment of the life sciences sector. It was incorporated on 20 September 1985 and has been in existence for over 41 years.

Its director Mahesh P Babani is #472 among India's richest people (2026). Its director Doppalapudi Bhaktavatsala Rao and family are #1,233 among India's richest people (2026).

The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U74220MH1985PTC037534. Its GSTIN is 27AAACP7722P1ZX (Maharashtra).

The company has an authorised share capital of ₹40 Cr and a paid-up capital of ₹36.27 Cr. It was formerly known as Prime Machine Company Private Limited. It is led by directors Bhaktavatsala Rao Doppalapudi (Managing Director) and Mahesh Purshottam Babani.

Its last annual general meeting (AGM) was held on 18 June 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Privihousea – 71 Ttc Thanebelapurroad Nearkoparkhairanerailwaystation, Navi Mumbai, Maharashtra, India – 400709.

As per the financials filed for FY 2025, the company reported a revenue of ₹6.15 Cr, a decline of 32% compared to the previous year. For the same year it recorded a net loss of ₹7.6 Cr (net margin -123.7%) and EBITDA of -₹5.3 Cr (EBITDA margin -86.2%). Revenue has grown at a compounded annual rate (CAGR) of 1% over three years and 5% over five years.

The company has about 38 employees on its provident fund (EPFO) records.

As per MCA filings, the company has open charges of ₹87.5 Lakh and satisfied charges of ₹22.2 Cr on record. Court records list 2 cases involving the company, including 2 filed against it; 1 case is pending. The company has 3 deals on record (2 secondary share transfers, 1 acquisition); the latest was in July 2012.

The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website privi.com.

Company details

CIN U74220MH1985PTC037534
Registration Number 037534
Incorporation Date 20 September 1985
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 18 June 2025
Date of Balance Sheet 31 March 2025
Parent Company Privi Speciality Chemicals Limited
Compliance Status Active Compliant

CIN history

Privi Biotechnologies has one previous CIN (Corporate Identification Number): U29220MH1985PTC037534. The current CIN is U74220MH1985PTC037534, which is the unique identifier assigned by the Registrar of Companies.

CINStatus
U74220MH1985PTC037534Current
U29220MH1985PTC037534Previous
Key People
Bhaktavatsala Rao Doppalapudi Managing Director Narayan Sreenivasan Iyer Cfo Mahesh Purshottam Babani Director

Recognitions & Rankings of Privi Biotechnologies

Contact details

Privi Biotechnologies Private Limited's registered office is in Navi Mumbai, Maharashtra. Its website is privi.com. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Website
    privi.com
  • Social Media
  • Registered Address
    Privihousea – 71 Ttc Thanebelapurroad Nearkoparkhairanerailwaystation, Navi Mumbai, Maharashtra, India – 400709
  • Industry
    Life Sciences, Biotechnology

To see the full contact details of Privi Biotechnologies Private Limited, buy the company report.

Comprehensive company report
Privi Biotechnologies Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Privi Biotechnologies is professional, scientific and technical activities. In detail, this covers other professional, scientific and technical activities.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
MProfessional, scientific and technical activities74Other professional, scientific and technical activities

To see the full business activity and turnover split of Privi Biotechnologies Private Limited, buy the company report.

Financials of Privi Biotechnologies Private Limited

FY 2025 filings available

Privi Biotechnologies Private Limited reported revenue of ₹6.15 Cr (down 32% YoY) for FY 2025.

Revenue · FY 2025
₹6.15 Cr ▼ 32%
Net loss · FY 2025
₹7.6 Cr margin -123.7%
EBITDA · FY 2025
-₹5.3 Cr margin -86.2%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▼ 32%
3 years · compounded
▲ 1%
5 years · compounded
▲ 5%
EBITDA CAGR growth
1 year
▼ 339%
3 years · compounded
▼ 173%
5 years · compounded
▼ 56%

Revenue fell 32% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 5%. EBITDA fell 339% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA-₹5.3 Cr
Profit Before Tax
Tax Expense
Net Profit (PAT)-₹7.6 Cr
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin-86.2%
Net Profit Margin-123.7%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Privi Biotechnologies Private Limited, buy the company report.

Board of directors and KMP of Privi Biotechnologies Private Limited

Privi Biotechnologies Private Limited currently reports 2 directors and 1 key managerial person. 7 former directors have served the organization.

Current Directors and KMP
NameDesignationAppointment DateTenureStatus
Bhaktavatsala Rao Doppalapudi
Also directs: Privi Speciality Chemicals Limited, Satellite Technologies Private Limited, Vivira Investment and Trading Private Limited
Managing Director06 Aug 201115 Years 3 MonthsCurrent
Narayan Sreenivasan IyerCfo14 Mar 20197 Years 7 MonthsCurrent
Mahesh Purshottam Babani
Also directs: Babani Brothers LLP, Pee Vee Premises LLP, Privi Speciality Chemicals Limited and 3 more
Director06 Aug 201115 Years 3 MonthsCurrent
View all directors and KMP

Auditor

Privi Biotechnologies Private Limited is audited by E.E SITABKHAN & C O . CHARTERED ACCOUNTANTS for the financial year 2023.

Auditor firmFinancial yearFirm registration number
E.E SITABKHAN & C O . CHARTERED ACCOUNTANTSFY 2023110300W

Shareholding

The shareholding of Privi Biotechnologies Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2023FY 2022FY 2021FY 2020FY 2019
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Privi Biotechnologies Private Limited, buy the company report.

Charges & borrowings

Open charges
₹87.5 Lakh
Satisfied charges
₹22.2 Cr
Breakdown by lending institutions
Others₹0.88 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
30 Mar 2016100033514Others₹87.5 LakhOpen
24 Jul 2018100197850Others₹4.2 CrSatisfied
03 Nov 201410541898Rbl Bank Limited₹15 CrSatisfied
14 Feb 200680005077State Bank of Hyderabad₹3 CrSatisfied

To see the full charge records of Privi Biotechnologies Private Limited, buy the company report.

Total charge records: 4 View all charges

Deals & funding

Privi Biotechnologies Private Limited has 3 deals on record (2 secondary share transfers, 1 acquisition); the latest was in July 2012.

Total deals
3
Secondary share transfers
2
Acquisition
1

Deals on record (3 of 3)

WhenDealAmountParties
Jul 2012Secondary share transferUndisclosedBuyer: Privi Organics Limited , an individual
Seller: 4 individuals
Sep 2011AcquisitionUndisclosedBuyer: Privi Organics Limited
Seller: Sainath Marketing Private Limited , Others Privi Biotechnologies Private Limited, 2 individuals
Sep 2006Secondary share transferUndisclosedBuyer: Sainath Marketing Private Limited
Seller: 2 individuals

Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.

MSME payment delays

No delayed payments to MSME suppliers are on our record for Privi Biotechnologies Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

Employees & EPFO

Privi Biotechnologies Private Limited has a workforce of 38 employees on its EPFO records as of Apr 06, 2024, across 1 active EPFO establishment.

Employee count
38
Active EPFO establishments
1
Employee growth
-7.32%

GST

Privi Biotechnologies has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
27AAACP7722P1ZXMaharashtraActive01 Jul 2017

To see the full GST registrations and return filing status of Privi Biotechnologies Private Limited, buy the company report.

Recent activity

Privi Biotechnologies Private Limited has 9 board changes on record since 2011: 3 appointments and 6 cessations. The latest: Bhaktavatsala Rao Doppalapudi ceased to be Director on 14 Mar 2019.

AGM
Privi Biotechnologies Private Limited last Annual general meeting of members was held on 18 Jun 2025 as per latest MCA records.
Filing
Privi Biotechnologies Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai.
Charges
A charge registered on 24 Jul 2018 via Charge ID 100197850 with Others was fully satisfied on 17 Jun 2019.
Ceased
Bhaktavatsala Rao Doppalapudi ceased to be Director.
Appointed
Narayan Sreenivasan Iyer was appointed as CFO.
Charges
A charge registered on 03 Nov 2014 via Charge ID 10541898 with Rbl Bank Limited was fully satisfied on 13 Feb 2019.
Charges
A charge with Others amounted to Rs. 4.20 Cr with Charge ID 100197850 was registered on 24 Jul 2018.
Ceased
Satan Santumal Bharwani ceased to be Director.
Charges
A charge with Others amounted to Rs. 0.88 Cr with Charge ID 100033514 was registered on 30 Mar 2016.
Charges
A charge with Rbl Bank Limited amounted to Rs. 15.00 Cr with Charge ID 10541898 was registered on 03 Nov 2014.
Charges
A charge registered on 14 Feb 2006 via Charge ID 80005077 with State Bank Of Hyderabad was fully satisfied on 17 Jul 2013.
Ceased
Hema Narendra Shah ceased to be Director.

8 earlier events are in the company report.

News

Frequently asked questions

Privi Biotechnologies is an active private limited company based in Navi Mumbai, Maharashtra, India. The company works in biotechnology, within the life sciences industry. It was incorporated on 20 September 1985 (41+ years old) and is registered under CIN U74220MH1985PTC037534.

Privi Biotechnologies has 3 current directors and KMP:

The latest financial statements of Privi Biotechnologies on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 18 June 2025. Year-wise statements from 2015 are in the company report.

The GSTIN of Privi Biotechnologies is 27AAACP7722P1ZX, registered in Maharashtra.

The CIN (Corporate Identification Number) of Privi Biotechnologies is U74220MH1985PTC037534. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Privi Biotechnologies has 2 court cases on record: 2 filed against it. 1 is pending.

Privi Biotechnologies was incorporated on 20 September 1985, making it 41+ years old. It is registered with the Registrar of Companies, Mumbai.

Privi Biotechnologies has 3 deals on record (2 secondary share transfers, 1 acquisition); the latest was in July 2012.

Bhaktavatsala Rao Doppalapudi ceased to be Director on 14 Mar 2019. Narayan Sreenivasan Iyer was appointed as CFO on 14 Mar 2019. Satan Santumal Bharwani ceased to be Director on 16 Feb 2018. Privi Biotechnologies has 9 board changes on record in total.

Privi Biotechnologies can be reached through the website privi.com. Its registered office is in Navi Mumbai, Maharashtra, India.